Drug formulary decisions--evaluating the risks and benefits of hormone replacement therapy.
Curtiss
Frederic R
FR
D015519:Bone Density; D002318:Cardiovascular Diseases / Q000517:prevention & control; D015914:Estrogen Replacement Therapy / Q000009:adverse effects / Q000379:methods*; D005260:Female; D005569:Formularies as Topic; D006801:Humans; D008329:Managed Care Programs; D010024:Osteoporosis / Q000517:prevention & control; D010919:Placebos; D016032:Randomized Controlled Trials as Topic; D018570:Risk Assessment; D016896:Treatment Outcome; D014481:United States
D010919:Placebos